Food News and Research

RSS

MHRA and FDA to inspect Chiron's Liverpool manufacturing facility

Chiron Corporation announced at a presentation at the 23rd Annual JPMorgan Healthcare Conference that the company anticipates that the UK Medicines and Healthcare products Regulatory Agency (MHRA), accompanied by U.S. Food and Drug Administration (FDA) inspectors as observers, will conduct a series of inspections of Chiron's Liverpool manufacturing facility.

13 Jan 2005

Alarming ignorance about cancer in Britain

There is an alarming ignorance about cancer and how to reduce the risk of the disease which is Britain's biggest killer – a special survey reveals today.

13 Jan 2005

Soy may reduce risk of cardiovascular disease

Every 34 seconds, an American man or woman dies of cardiovascular disease. Now, research suggests that a diet rich in soybean oil can help. Two new studies shed light on the power of alpha-linolenic acid (ALA) to reduce heart disease risk. Soybean oil provides an excellent source of ALA, as do leafy greens, some nuts and flax.

12 Jan 2005

Added sugar in fruit-flavored drinks and cola-type soft drinks undoes the good done by vegetables

American preschoolers get about 14 to 17 teaspoons of added sugar a day, on average, mostly from fruit-flavored drinks, high-fat desserts and cola-type soft drinks which displace the grain, vegetable, fruit and dairy food groups and lower the quality of their diet, a Penn State study has shown.

12 Jan 2005

Euro funding for diabetes and exercise research

Researchers at The University of Nottingham are among a network of European scientists who have been awarded €12.7 million (around £8.7 million) for a study into the relationship between lack of exercise and the development of diabetes — and the health benefits of regular exercise in its prevention and cure.

12 Jan 2005

Latest Canadian mad cow case poses no threat

The recently confirmed case of mad cow disease in Canada is an isolated case and does not represent a threat to the food chain, according to the Pan American Health Organization’s top expert on the issue.

12 Jan 2005

Study links meat consumption to colon cancer

A major American Cancer Society study finds people who reported the highest consumption of red and processed meat had a significantly higher risk of colorectal cancer than those who reported the least consumption.

12 Jan 2005

Honeycomb-like polymer implant helps re-build the faces of children

British and Russian surgeons are using a revolutionary honeycomb-like polymer implant to help re-build the faces of children injured in accidents or born with serious defects. The material bonds with bone without causing adverse reactions.

12 Jan 2005

What makes an allergen an allergen?

An enduring mystery for allergy researchers has been the unpredictable distribution of allergens in plants. For example, being allergic to birch pollen can predispose a person to allergy from distantly related plant foods such as celery, apple or soy.

12 Jan 2005

Safety established for Vaxin's first flu vaccine in clinical trial

Vaxin Inc., a privately-held biotechnology company, has demonstrated, in a Phase I human clinical study, that the company's recombinant influenza vaccine provides a potential alternative to traditional flu vaccines.

12 Jan 2005

Campral, first new treatment for alcoholism in ten years

Forest Laboratories announced that Campral (acamprosate calcium) Delayed- Release Tablets are now available to physicians, patients and pharmacies nationwide.

12 Jan 2005

Gold is rewriting the script

Pen strokes of the rich and famous and remote-controlled drug delivery systems of the future have been given the golden treatment in a new technology being developed at the University of Melbourne.

11 Jan 2005

Lack of sleep could make you fat

Lack of sleep could make you fat. In an editorial published in the Jan. 10 issue of the Archives of Internal Medicine, two Northwestern University researchers stress the need to better understand the growing epidemic of obesity in the United States by studying how loss of sleep alters the complex metabolic pathways that control appetite, food intake and energy expenditure.

10 Jan 2005

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Millennium Pharmaceuticals today announced, in collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC, the initiation of VISTA (Velcadeas Initial Standard Therapy in multiple myeloma: Assessment with melphalan and prednisone), a multicenter, international phase III clinical trial of Velcadein combination with melphalan and prednisone versus melphalan and prednisone in patients with newly diagnosed multiple myeloma (MM) who are not transplant candidates.

10 Jan 2005

Trial of naproxen and celecoxib suspended

Use of study drugs in a large, federally funded Alzheimer prevention trial has been suspended following a decision by the study's leadership on Dec. 17, 2004.

9 Jan 2005

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.

9 Jan 2005

FDA approves Abraxane for metastatic breast cancer

American Pharmaceutical Partners, Inc. and American Bioscience, Inc. (ABI) announced that the U.S. Food and Drug Administration (FDA) has approved Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in metastatic breast cancer.

9 Jan 2005

How consumers process negative food messages

No saturated fat. Less filling. No MSG added. No trans fats. No sugar added… Called negations, advertising messages that contain terms like 'not' or 'no' are meant to highlight some distinctive characteristic about the product being sold.

9 Jan 2005

FDA clearance to test influenza vaccine, Fluviral

ID Biomedical Corporation announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin immediate clinical testing of its influenza vaccine, Fluviral, in the United States under an Investigational New Drug application (IND).

7 Jan 2005

New form of treatment for cancer of the larynx

Surgeons at Montefiore Medical Center are using a new form of treatment for cancer of the larynx that allows for quicker recovery and shorter hospital stays, and saves the voice box so patients retain the ability to speak.

7 Jan 2005